![Kim Stratton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kim Stratton
Direktor/Vorstandsmitglied bei
RECORDATI
Profil
Kim Stratton is currently a Non-Executive Director at Recordati SpA since 2021, a Director at the European Federation of Pharmaceutical Industries & Assns, a Director at Vifor Pharma Management AG, and an Independent Director at Novonesis (Novozymes A) starting in 2024.
Former roles include Chief Executive Officer at Strategic Partners A from 2019 to 2020, Chief Executive Officer & Managing Director at Centogene NV from 2021 to 2023, Chief Executive Officer at Centogene GmbH, Independent Director at Corden Pharma Fribourg SA, Independent Director at Novozymes A from 2017 to 2023, Head-Marketing at Bristol Myers Squibb Co., Head-United Kingdom Respiratory Business at AstraZeneca PLC, Head-Group Country Management & External Affairs at Novartis AG from 2010 to 2013, Sales Representative at GlaxoSmithKline Investments Pty Ltd., Chief Operating Officer at Novartis UK Ltd., and Head-International Commercial at Shire International GmbH.
Aktive Positionen von Kim Stratton
| Unternehmen | Position | Beginn |
|---|---|---|
| RECORDATI | Direktor/Vorstandsmitglied | 16.12.2021 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Direktor/Vorstandsmitglied | - |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kim Stratton
| Unternehmen | Position | Ende |
|---|---|---|
| STRATEGIC PARTNERS A/S | Vorstandsvorsitzender | 10.12.2020 |
| NOVARTIS AG | Public Communications Contact | 01.03.2013 |
Centogene GmbH
 Centogene GmbH Medical/Nursing ServicesHealth Services Owns, manages and operates diagnostics laboratory | Vorstandsvorsitzender | - |
| CENTOGENE N.V. | Vorstandsvorsitzender | - |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Recordati SpA
 Recordati SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is a company based in Boronia, Australia. The Australian company was founded in 2001. | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Health Technology |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Shire International GmbH
 Shire International GmbH Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Centogene NV
 Centogene NV Medical SpecialtiesHealth Technology Provides genetic diagnostic analyses of rare inherited diseases | Health Technology |
Centogene GmbH
Centogene GmbH Medical/Nursing ServicesHealth Services Owns, manages and operates diagnostics laboratory | Health Services |
